According to the World health Organization (WHO) report, tuberculosis (TB) is a disease that is caused by a bacterium, which resulted in estimated 9 million new cases in 2013 and 1.5 million deaths. Over 90% of TB cases occur in low and middle income countries that have fragile healthcare infrastructures and constrained resources available, and therefore struggle to tackle one of the world’s deadliest communicable diseases. The evidence showed that annually over US$ 1 billion is spent worldwide on TB diagnostics now.
The global tuberculosis diagnostics market is expected to reach USD 3.1 billion by 2024, according to a new report by Grand View Research, Inc. The potential markets for improved tests to detect active disease are huge. There are 80 million for point-of-care test requirement, 50 million for smear replacement needs and 20 million tests for culture replacement tests needs per year. Our new concept TB diagnostic system will provide point-of-care test needs of disease by the means of quick, accuracy and low cost.